South Africa - 2015 - Health

Introduction of New Drugs and Drug Regimens for the Management of Drug-Resistant Tuberculosis in South Africa: Policy framework

Ministry of Health, South Africa

The main objectives of this policy are to increase access to new drugs and regimens for all DR-TB patients in South Africa; to increase public access to new drugs and regimens; and to improve the survival and treatment success rate of patients with DR-TB in South Africa.

Process Flow

Compare Versions Please select two versions

Introduction of New Drugs and Drug Regimens for the Management of Drug-Resistant Tuberculosis in South Africa: Policy framework Current Version

January 2022

The main objectives of this policy are to increase access to new drugs and regimens for all DR-TB patients in South Africa; to increase public access to new drugs and regimens; and to improve the survival and treatment success rate of patients with DR-TB in South Africa.

Request Expert Analysis

Ask one of our policy analysts to take an in-depth look at this policy and provide you with a written summary. An additional cost may apply. Please let us know what questions you are looking to answer.

Thank you for requesting an expert analysis

A member of our team will review your request and reply back to the email address on file.